Niklas Larsson

2.3k total citations · 1 hit paper
24 papers, 1.8k citations indexed

About

Niklas Larsson is a scholar working on Surgery, Food Science and Molecular Biology. According to data from OpenAlex, Niklas Larsson has authored 24 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 7 papers in Food Science and 6 papers in Molecular Biology. Recurrent topics in Niklas Larsson's work include Probiotics and Fermented Foods (7 papers), Central Venous Catheters and Hemodialysis (4 papers) and Gut microbiota and health (4 papers). Niklas Larsson is often cited by papers focused on Probiotics and Fermented Foods (7 papers), Central Venous Catheters and Hemodialysis (4 papers) and Gut microbiota and health (4 papers). Niklas Larsson collaborates with scholars based in Sweden, United Kingdom and Australia. Niklas Larsson's co-authors include Thomas Elebring, Peter J. Greasley, Stephan Hjorth, Erik Ryberg, Nils-Olov Hermansson, Tomáš Drmota, Peter Nilsson, S. Sjögren, Gunilla Önning and Irini Lazou Ahrén and has published in prestigious journals such as PLoS ONE, FEBS Letters and Journal of Colloid and Interface Science.

In The Last Decade

Niklas Larsson

24 papers receiving 1.8k citations

Hit Papers

The orphan receptor GPR55 is a novel cannabinoid receptor 2007 2026 2013 2019 2007 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The orphan receptor GPR55 is a novel cannabinoid receptor
    2007 1.2k citations Erik Ryberg, Niklas Larsson et al. British Journal of Pharmacology profile →

Peers

Niklas Larsson
Geoffrey W. Guy United Kingdom
Keiichi Irie Japan
Wayne S. Schwark United States
Zhenwen Zhang China
Maciej Sałaga Poland
Andrew Yates United Kingdom
Amina M. Bagher Saudi Arabia
Sue Aspley United Kingdom
Carmen Mannucci Italy
Shahram Ejtemaei Mehr Iran
Geoffrey W. Guy United Kingdom
Niklas Larsson
Citations per year, relative to Niklas Larsson Niklas Larsson (= 1×) peers Geoffrey W. Guy

Countries citing papers authored by Niklas Larsson

Since Specialization
Citations

This map shows the geographic impact of Niklas Larsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Niklas Larsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Niklas Larsson more than expected).

Fields of papers citing papers by Niklas Larsson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Niklas Larsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Niklas Larsson. The network helps show where Niklas Larsson may publish in the future.

Co-authorship network of co-authors of Niklas Larsson

This figure shows the co-authorship network connecting the top 25 collaborators of Niklas Larsson. A scholar is included among the top collaborators of Niklas Larsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Niklas Larsson. Niklas Larsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Granberg, Kenneth L., Shigeki Sakamaki, Masakazu Fujio, et al.. (2024). Identification of Novel Series of Potent and Selective Relaxin Family Peptide Receptor 1 (RXFP1) Agonists. Journal of Medicinal Chemistry. 67(6). 4442–4462. 4 indexed citations
2.
Önning, Gunilla, Caroline Montelius, Magnus Hillman, & Niklas Larsson. (2023). Intake of Lactiplantibacillus plantarum HEAL9 Improves Cognition in Moderately Stressed Subjects: A Randomized Controlled Study. Nutrients. 15(15). 3466–3466. 22 indexed citations
3.
Durek, Thomas, Quentin Kaas, Andrew M. White, et al.. (2021). Melanocortin 1 Receptor Agonists Based on a Bivalent, Bicyclic Peptide Framework. Journal of Medicinal Chemistry. 64(14). 9906–9915. 7 indexed citations
4.
Nordström, Elisabet Arvidsson, Cristina Teixeira, Caroline Montelius, Bengt Jeppsson, & Niklas Larsson. (2021). Lactiplantibacillus plantarum 299v (LP299V®): three decades of research. Beneficial Microbes. 12(5). 441–466. 60 indexed citations
5.
Önning, Gunilla, et al.. (2021). New Lactiplantibacillus plantarum and Lacticaseibacillus rhamnosus strains: well tolerated and improve infant microbiota. Pediatric Research. 91(7). 1849–1857. 10 indexed citations
6.
7.
8.
Schmitter, Tim, et al.. (2018). Ex vivo anti-inflammatory effects of probiotics for periodontal health. Journal of Oral Microbiology. 10(1). 1502027–1502027. 27 indexed citations
9.
Woynarowski, Marek, Irini Lazou Ahrén, Jarosław Kierkuś, et al.. (2017). Efficacy and Safety of Lactobacillus plantarum DSM 9843 (LP299V) in the Prevention of Antibiotic-Associated Gastrointestinal Symptoms in Children—Randomized, Double-Blind, Placebo-Controlled Study. The Journal of Pediatrics. 186. 82–86. 35 indexed citations
10.
Fjellström, Ola, Niklas Larsson, Takuma Tsuchida, et al.. (2015). Novel Zn2+ Modulated GPR39 Receptor Agonists Do Not Drive Acute Insulin Secretion in Rodents. PLoS ONE. 10(12). e0145849–e0145849. 16 indexed citations
11.
Ploj, Karolina, et al.. (2014). Partial agonist activity of R3(BΔ23–27)R/I5 at RXFP3 – Investigation of in vivo and in vitro pharmacology. European Journal of Pharmacology. 747. 123–131. 4 indexed citations
12.
Murray, David C., et al.. (2014). Using the BioAssay Ontology for Analyzing High-Throughput Screening Data. SLAS DISCOVERY. 20(3). 402–415. 9 indexed citations
13.
Berggren, Anna, Irini Lazou Ahrén, Niklas Larsson, & Gunilla Önning. (2010). Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections. European Journal of Nutrition. 50(3). 203–210. 104 indexed citations
14.
Hermansson, Nils-Olov, David Morgan, Tomáš Drmota, & Niklas Larsson. (2007). Adenosine is not a direct GHSR agonist – artificial cross‐talk between GHSR and adenosine receptor pathways. Acta Physiologica. 190(1). 77–86. 11 indexed citations
15.
Ryberg, Erik, Niklas Larsson, S. Sjögren, et al.. (2007). The orphan receptor GPR55 is a novel cannabinoid receptor. British Journal of Pharmacology. 152(7). 1092–1101. 1249 indexed citations breakdown →
16.
Ryberg, Erik, Huy Khang Vu, Niklas Larsson, et al.. (2004). Identification and characterisation of a novel splice variant of the human CB1 receptor. FEBS Letters. 579(1). 259–264. 109 indexed citations
17.
Eriksson, E., Niklas Larsson, Petre Nitescu, et al.. (1991). Penetration forces in cannulation of the dorsal veins of the hand: I. A comparison between polyurethane (Insyte®) and polytetrafluoroethylene (Venflon®) cannulae. Acta Anaesthesiologica Scandinavica. 35(4). 306–314. 7 indexed citations
18.
Nitescu, Petre, Niklas Larsson, E. Eriksson, et al.. (1990). Disturbances of blood‐flow velocity in the dorsal veins of the hand after vein cannulation and cannula fixation in the anaesthetised patient. Acta Anaesthesiologica Scandinavica. 34(2). 120–125. 9 indexed citations
19.
Larsson, Niklas, K Stenberg, L.E. Linder, & I Curelaru. (1989). Cannula thrombophlebitis: a study in volunteers comparing polytetrafluoroethylene, polyurethane, and polyamide–ether–elastomer cannulae. Acta Anaesthesiologica Scandinavica. 33(3). 223–231. 21 indexed citations
20.
Larsson, Niklas, et al.. (1978). SEM-study of rubber stoppers for parenteral drugs. 40. 1242–1245. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Geoffrey W. Guy Breakdown of academic impact, for papers by Keiichi Irie Breakdown of academic impact, for papers by Wayne S. Schwark Breakdown of academic impact, for papers by Zhenwen Zhang Breakdown of academic impact, for papers by Maciej Sałaga Breakdown of academic impact, for papers by Andrew Yates Breakdown of academic impact, for papers by Amina M. Bagher Breakdown of academic impact, for papers by Sue Aspley Breakdown of academic impact, for papers by Carmen Mannucci Breakdown of academic impact, for papers by Shahram Ejtemaei Mehr
Rankless by CCL
2026